US 12037390
Leptin antibodies and method of reducing leptin
granted A61KA61K2039/505A61P
Quick answer
US patent 12037390 (Leptin antibodies and method of reducing leptin) held by The Board of Regents of the University of Texas System expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505, A61P, A61P3/04, A61P3/10